Company Profiles

When assessing a competitor, it is helpful to have all the information about the company—financial profile, portfolio, strategy, and structure—in one report or source. Many market research firms and publishers prepare pharmaceutical company profiles on an ad hoc basis or to capture a particular market. A complete listing of all available company profiles is beyond the scope of this chapter. The sources listed here produce reports on a regular schedule and include the most important elements for a complete company assessment.

IMS Company Profiles. IMS Health, 660 West Germantown Pike, Plymouth Meeting, PA 19462-0905, U.S.A. Phone: +1 610-834-5000. URL: IMS Company Profiles (previously known as the Pharmaceutical Company Profiles) are in-depth company reviews that are updated annually. IMS covers about 100 companies. The profiles provide information on company strategy, financial performance, product pipeline, alliances, marketed products, and key events. IMS gathers the data for the reports from their own databases as well as from public news sources, analyst reports, and interviews with company executives. The profiles are available through IMS. High-level summaries covering companies and their subsidiaries are available online.

Pharmaceutical Companies Analysis. Espicom Business Intelligence, Lincoln House, City Fields Business Park, City Fields

Way, Chichester, West Sussex, P020 2FS, U.K. Phone: +441243-533322, Fax: +44-1243-533418. North American contact: 116 Village Boulevard, Princeton Forrestal Village, Princeton, NJ 08540, U.S.A. Phone: +1 609-9512227. Fax: +1 6097347428. URL: Pharmaceutical Companies Analysis (PCA) covers approximately 40 of the major global pharmaceutical companies. The reports include financial position, company history, strategy, alliances, marketed products, and pipeline drug portfolio. PCA reports are updated daily with the latest news. In conjunction with the PCA, Espi-com also offers the Pharmaceutical Companies Insight, a daily online intelligence monitoring service that covers the latest news, alliances, financials, marketed products, and R&D. Access is available through a subscription to Espicom. PCA reports are available through third party market research vendors.

PharmaDeals. PharmaVentures Ltd, Magdalen Centre, Oxford Science Park, Oxford 0X4 4GA, U.K. Phone: +441865-784-177, Fax: +44-1865-784-178. E-mail: [email protected] URL: North American contact: Financial District Center, 425 Market Street, Suite 2200, San Francisco, CA 94105, U.S.A. Phone: +1 415-512-6488, Fax: +1 415-397-6309. Pharma-Deals, produced by PharmaVentures, is primarily a resource for tracking alliances within the pharmaceutical industry. There is a company profile database that covers European biopharmaceutical and pharmaceutical companies and Japanese pharmaceutical companies. The purpose of this database is to aid these companies in seeking partners outside their location. The profiles of European companies contain information on strategy (particularly partnering and alliance strategy), marketed products, drug pipeline, history, financial results, and company contact information. The Japanese company profiles include information on infrastructure, financial results, marketed products, drug pipeline, and marketing capabilities. Reports are available through online subscription from PharmaVentures.

PharmaVitae. Datamonitor, Charles House, 108-110 Finchely Road, London NW3 5JJ, U.K. Phone: +44-20-7675-7000,

Fax: +44-20-7675-7500. E-mail: [email protected]. URL: North American contact: 245 Fifth Avenue, 4th Floor, New York, NY 10016, U.S.A. Phone: +1 212-686-7400, Fax: +1 212-686-2626. E-mail: [email protected]. Datamonitor's PharmaVitae profiles offer an assessment of companies' strategies, market positions, key alliances, pipelines, and top-level financial data. The profiles cover the 40 leading pharmaceutical and biotechnology companies with annual updates provided on a rotating basis. Each profile has an Interactive Analysis tool, which allows users to access. Datamonitor's proprietary database of global market forecasts to model the company's projected portfolio and financial position. In 2003, Datamonitor introduced the PharmaVi-tae Comparator Tool, which collates the data in the individual companies' Interactive Analysis databases and compares the top 40 companies' current and projected positions by strategy, drug portfolio, and financial position. The profiles are available through Datamonitor and third party market research vendors. The Interactive Analysis tool and the Comparator Tool are only available through Datamonitor.

Wood Mackenzie. Kintore House, 74-77 Queen Street, Edinburgh, EH2 4NS, U.K. Phone: +44-131-243-4400, Fax: +44131-243-4495. E-mail: [email protected]. URL: http:// North American contact: 30 Rowes Wharf, 2nd Floor, Boston, MA 02110, U.S.A. Phone: +1 617-535-1000, Fax: +1 617-535-1333. E-mail: [email protected] com. Wood MacKenzie's Company Reviews provide summaries of the top pharmaceutical companies. The reports cover the top 25 pharmaceutical companies, around 23 of the mid-cap pharmaceutical companies, and the 17 leading biotechnology companies. The full reports are updated annually on a rotating basis with news updates provided more frequently. The Company Reviews cover company history, strategic events, financial results and analysis, company structure, therapeutic profile, drug pipeline, and key issues. Wood MacKenzie also has smaller profiles covering emerging companies in specific technology areas such as therapeutic MAbs, novel oncology, gene therapy, and discovery technology. Wood

MacKenzie has recently introduced the Corporate Franchise Analysis (CFA) module, which provides competitive analysis from a corporate and therapeutic perspective. Access is available through online subscription.

Was this article helpful?

0 0

Post a comment